These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. Decaudin D; de Cremoux P; Sastre X; Judde JG; Nemati F; Tran-Perennou C; Fréneaux P; Livartowski A; Pouillart P; Poupon MF Int J Cancer; 2005 Feb; 113(5):849-56. PubMed ID: 15499612 [TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease. Re D; Wickenhauser C; Ahmadi T; Buchdunger E; Kochanek M; Diehl V; Wolf J Br J Cancer; 2002 Apr; 86(8):1333-5. PubMed ID: 11953894 [TBL] [Abstract][Full Text] [Related]
33. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
34. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors. Huang HM; Liu JC J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173 [TBL] [Abstract][Full Text] [Related]
35. Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562. Jakubowska J; Stasiak M; Szulawska A; Bednarek A; Czyz M Acta Biochim Pol; 2007; 54(4):839-46. PubMed ID: 17957275 [TBL] [Abstract][Full Text] [Related]
36. Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants. Guida T; Anaganti S; Provitera L; Gedrich R; Sullivan E; Wilhelm SM; Santoro M; Carlomagno F Clin Cancer Res; 2007 Jun; 13(11):3363-9. PubMed ID: 17545544 [TBL] [Abstract][Full Text] [Related]
37. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936 [TBL] [Abstract][Full Text] [Related]
38. The effect of imatinib mesylate (Glivec) on human tumor-derived cells. Knight LA; Di Nicolantonio F; Whitehouse PA; Mercer SJ; Sharma S; Glaysher S; Hungerford JL; Hurren J; Lamont A; Cree IA Anticancer Drugs; 2006 Jul; 17(6):649-55. PubMed ID: 16917210 [TBL] [Abstract][Full Text] [Related]
39. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells. Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913 [TBL] [Abstract][Full Text] [Related]
40. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Zermati Y; De Sepulveda P; Féger F; Létard S; Kersual J; Castéran N; Gorochov G; Dy M; Ribadeau Dumas A; Dorgham K; Parizot C; Bieche Y; Vidaud M; Lortholary O; Arock M; Hermine O; Dubreuil P Oncogene; 2003 Feb; 22(5):660-4. PubMed ID: 12569358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]